BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6357936)

  • 1. Effects of propranolol on renal blood flow and renal function in patients with cirrhosis.
    Bataille C; Bercoff E; Pariente EA; Valla D; Lebrec D
    Gastroenterology; 1984 Jan; 86(1):129-33. PubMed ID: 6357936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis.
    Bacq Y; Gaudin C; Hadengue A; Roulot D; Braillon A; Moreau R; Lebrec D
    Hepatology; 1991 Sep; 14(3):483-7. PubMed ID: 1874493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepancy between wedged hepatic venous pressure and portal venous pressure after acute propranolol administration in patients with alcoholic cirrhosis.
    Valla D; Bercoff E; Menu Y; Bataille C; Lebrec D
    Gastroenterology; 1984 Jun; 86(6):1400-3. PubMed ID: 6714569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of nipradilol and the acute and chronic splanchnic hemodynamic effects of a new beta-blocker with nitrovasodilating properties in patients with liver cirrhosis.
    Sugano S; Kawafune T; Suzuki T; Kubota M; Okajima T; Sumino Y; Akita H
    Am J Gastroenterol; 1995 May; 90(5):788-93. PubMed ID: 7733089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Al Bokharhii J; Pappas C; Katsaraki A; Tsianos EV
    Am J Gastroenterol; 2005 Apr; 100(4):879-85. PubMed ID: 15784036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
    Feu F; Bordas JM; Luca A; García-Pagán JC; Escorsell A; Bosch J; Rodés J
    Hepatology; 1993 Nov; 18(5):1082-9. PubMed ID: 8225212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
    Albillos A; Lledó JL; Rossi I; Pérez-Páramo M; Tabuenca MJ; Bañares R; Iborra J; Garrido A; Escartín P; Bosch J
    Gastroenterology; 1995 Oct; 109(4):1257-65. PubMed ID: 7557093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis.
    Turnes J; Hernández-Guerra M; Abraldes JG; Bellot P; Oliva R; García-Pagán JC; Bosch J
    Hepatology; 2006 Jan; 43(1):34-41. PubMed ID: 16374847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hypotensive effects of oral and intravenous propranolol: early alterations in peripheral resistance.
    Fagan TC; Gourley LA; Sawyer PR; Lee JT; Walle T; Gaffney TE
    J Clin Hypertens; 1986 Mar; 2(1):21-9. PubMed ID: 3723158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and pharmacokinetic study of propranolol and atenolol in cirrhosis patients.
    Rocher I; Decourt S; Leneveu A; Lebrec D; Rosier SP; Flouvat B
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):406-10. PubMed ID: 4044073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of propranolol on hepatic blood flow in patients with cirrhosis.
    Braillon A; Jirón MI; Valla D; Calès P; Lebrec D
    Clin Pharmacol Ther; 1985 Apr; 37(4):376-80. PubMed ID: 3978998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
    La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
    Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral propranolol administration on azygos, renal and hepatic uptake and output of catecholamines in cirrhosis.
    Bendtsen F; Christensen NJ; Sørensen TI; Henriksen JH
    Hepatology; 1991 Aug; 14(2):237-43. PubMed ID: 1860681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal.
    Henriksen JH; Holst JJ; Møller S; Brinch K; Bendtsen F
    Hepatology; 1999 Jun; 29(6):1818-24. PubMed ID: 10347125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
    Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Cavasin L; Gatta A
    Aliment Pharmacol Ther; 2005 Sep; 22(5):433-9. PubMed ID: 16128681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of antihypertensive therapy with guanabenz and propranolol on renal vascular resistance and left ventricular mass.
    Mosley C; O'Connor DT; Taylor A; Slutsky RA; Cervenka J
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S757-61. PubMed ID: 6084120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.